Olmesartan medoxomil side effects, by duration, gender and age (a phase IV clinical study of FDA data)
Summary:
Side effects are reported by people who take Olmesartan medoxomil (olmesartan medoxomil). Common side effects include asthenia among females and atrial fibrillation among males.
The phase IV clinical study is created by eHealthMe based on 14,971 reports from the FDA, and is updated regularly.
What is Olmesartan Medoxomil?
Olmesartan medoxomil has active ingredients of olmesartan medoxomil. It is often used in high blood pressure. eHealthMe is studying from 15,240 Olmesartan medoxomil users. Check the latest studies of Olmesartan medoxomil.
14,971 people who take Olmesartan Medoxomil and have side effects are studied.

What are the common side effects of Olmesartan medoxomil, by gender? *
What are the common side effects of Olmesartan medoxomil, by age (0-1 to 60+)? *
What are the common side effects of Olmesartan medoxomil, by the time people have been on the drug (< 1 month to 10+ years)? *
* Approximation only. Some reports may have incomplete information.
Do you take Olmesartan medoxomil?
- Personalize this study to your gender and age- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
How the study uses the data?
The study is based on olmesartan medoxomil (the active ingredients of Olmesartan medoxomil) and Olmesartan medoxomil (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered.
Related studies are listed below in case you need more information:
Alternative drugs to, pros and cons of Olmesartan medoxomil:
- Olmesartan medoxomil (15,240 reports)
All Olmesartan medoxomil side effects from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zWho is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Fludrocortisone Acetate cause Pancreatitis? - 16 seconds ago
- Drug interactions of Cosentyx and Kayexalate - 17 seconds ago
- Drug interactions of Naproxen and Metolazone - 26 seconds ago
- Drug interactions of Metoclopramide Hydrochloride and Atarax - 46 seconds ago
- Adenocarcinoma and Aseptic Necrosis - 48 seconds ago
- Drug interactions of Metoclopramide Hcl and Ranitidine - 49 seconds ago
- Drug interactions of Biaxin and Milk Of Magnesia - 53 seconds ago
- Could Benicar Hct cause Itching? - 55 seconds ago
- Could Darvocet cause Failure To Thrive? - 56 seconds ago
- Drug interactions of Combivent and Aciphex - a minute ago